TRIM22 confers poor prognosis and promotes epithelial-mesenchymal transition through regulation of AKT/GSK3β/β-catenin signaling in non-small cell lung cancer

Expression pattern and biological roles of TRIM22 remains unknown in most human cancers. The present study aims to discover its clinical significance and function in human non-small cell lung cancer (NSCLC). Immunohistochemistry was used to examine TRIM22 expression in 126 cases of NSCLC specimens....

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Liu, Li, Zhou, Xiao-Ming, Yang, Fang-Fei, Miao, Yuan, Yin, Yan, Hu, Xue-Jun, Hou, Gang, Wang, Qiu-Yue, Kang, Jian
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2017
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5617487/
https://ncbi.nlm.nih.gov/pubmed/28977927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18911
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы